Skip to main content
logo
NRx Pharmaceuticals, Inc. (NRXP)
NASDAQ: NRXP · Real-Time Price · USD
2.920
+0.050 (1.74%)
At close: Sep 29, 2026, 4:00 PM EDT
2.900
-0.020 (-0.68%)
Pre-market: Sep 30, 2026, 4:02 AM EDT

NRx Pharmaceuticals Financials Overview

Millions USD. Fiscal year is Jan - Dec.

Revenue & Profits
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
3.391.23----
Revenue Growth
------
Gross Profit
1.580.72----
Operating Income
-19.96-16.19-19.7-27.59-44.34-94.43
Net Income
-23.48-28.62-25.13-30.16-39.75-93.06
Earnings Per Share
-0.78-1.34-2.36-3.98-6.04-74.40
EPS Growth
------

Cash & Debt
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
26.697.81.444.620.0527.61
Total Debt
0.830.636.269.1610.530.52
Net Cash (Debt)
25.857.17-4.81-4.579.5327.09
Net Cash Growth
-----64.82%2450.57%
Net Cash Per Share
0.850.33-0.45-0.601.455.77

Cash Flow & CapEx
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
-19.77-14.11-10.64-21.66-39.76-37.7
Capital Expenditures
-0.9---0-0.01-0.01
Free Cash Flow
-20.67-14.11-10.64-21.66-39.77-37.71
Free Cash Flow Growth
------

Margins
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Gross Margin
46.64%58.78%----
Operating Margin
-588.21%-1321.47%----
Pretax Margin
-691.81%-2336.49%----
Profit Margin
-691.81%-2336.49%----
FCF Margin
-609.04%-1152.00%----

Valuation
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Forward PE
-39.16----
PS Ratio
37.2265.49----